CO₂ Incubator Market By Product Type (Water-Jacketed CO₂ Incubators, Air-Jacketed CO₂ Incubators, Direct Heat CO₂ Incubators, Others); By Capacity (Below 100 Liters, 100–200 Liters, Above 200 Liters); By Application (Laboratory Research and Clinical Applications, In Vitro Fertilization, Others); By Geography, Segment revenue estimation, Forecast, 2024–2032.

The co2 incubator market was worth USD 730 billion in 2023 and will be worth USD 1208.14 billion by 2030, growing at a CAGR of 6.5% during the forecast period.

 

Carbon dioxide (CO2) incubators are specialized laboratory instruments that develop and support the necessary environmental conditions for cultivating cells, tissues, and microorganisms on culture media. These incubators control temperature, humidity, and CO2 levels to portray physiologic conditions necessary for biochemical reactions. Most widely used in cell biology, microbiology, cancer research, or IVF, CO2 incubators must maintain the proper conditions to avoid contamination or culture deterioration. Stem cells are crucial in sciences such as regenerative medicine, drug trialing, and stem cell science by offering a stable setting since steady conditions are needed in many surroundings.

 

Market Dynamics

One of the main forces driving the growth of the CO2 incubator market is the rising need for cell-based therapies and regenerative medicine. The global cell therapy market size was USD 7.8 billion in 2022 and is expected to reach USD 23 billion by 2028, growing a CAGR of 19.8%. The demand increases due to stem-cell research progress and creative forms of chronic disease treatment. In these fields, it is critically important to maintain CO2 incubators to cultivate cells and promote efficient tissue engineering. For example, in 2023, scientists at the University of California, San Francisco, created a technique of a new stem-cell therapy for Type 1 diabetes using CO2 incubators for growing insulin-producing cells. This underlines the importance of important CO2 incubators in stimulating medical innovations and therapies.

 

A major limitation that exists in the market for CO2 incubators is that the more sophisticated models cost between $5,000 and more than $20,000. This huge capital issue presents some challenges to other relatively small research centers and other facilities that may not be able to invest in this solution. For this reason, manufacturers are developing affordable designs and employing viable methods of financing these all-importance devices.

 

One major opportunity of the current CO2 incubator market is to use the current and future state of technology to increase accuracy and optimize methods for CO2 incubation for cell cultures. For instance, the incubators that are specifically developed to act as real-time monitors are useful as they enable constant tracking of culture conditions needed for cell growth. Moreover, implementing automated control systems enables temperature and optimum humidity filtration and checks and balances for CO2 to avoid contamination and individual blunders. Newer innovations are incubators with a remote monitoring system, where the researchers can monitor the experiment from any position and make the lab practice more flexible and efficient. These technologies not only increase the certainty of experimental results but also add new areas of employment of CO2 incubators in different scientific and medical fields.

 

 

Market Segmentation

Product Type:

• Water-Jacketed CO2 Incubators

• Air-Jacketed CO2 Incubators

• Direct Heat CO2 Incubators

• Others

 

Capacity:

• Below 100 Liters

• 100–200 Liters

• Above 200 Liters

 

Application:

• Laboratory Research and Clinical Applications

• In Vitro Fertilization

• Others

 

End User:

• Biotechnology and Pharmaceutical Companies

• Research Institutes and Universities

• Hospitals and Medical Centers

 

By Region

North America

• US

• Mexico

• Canada

• Rest of North America

 

Europe

• Switzerland

• Russia

• France

• Germany

• U.K

• Finland

• Turkey

• Netherlands

• Belgium

• Spain

• Italy

• Rest of Europe

 

Asia Pacific

• India

• China

• South Korea

• Japan

• Singapore

• Thailand

• Indonesia

• Malaysia

• Philippines

• Australia

• Rest of Asia-Pacific

 

LAMEA

• Brazil

• Argentina

• Uruguay

• Saudi Arabia

• Rest of LAMEA

 

 

Segment Analysis of CO2 Incubator Market

By Product Type:

Leading Segment: Water-Jacketed CO2 Incubators

Water-jacketed CO2 incubators hold the largest market share in the CO2 incubator market due to their ability to maintain a stable & uniform temperature, providing an ideal environment for cell culture and microbiological studies. The market share of water-jacketed CO2 incubators is estimated to be around 45% of the total CO2 incubator market. These incubators are widely used in laboratories, clinical applications, and biotechnology industries. Their ability to offer precise temperature control makes them the preferred choice for sensitive applications such as tissue culture and fermentation.

Fastest-Growing Segment: Air-Jacketed CO2 Incubators

Air-jacketed CO2 incubators are the fastest-growing segment in the CO2 incubator market, expected to witness a CAGR of 6.5% during the forecast period. These incubators are gaining popularity due to their cost-effectiveness, ease of maintenance & energy efficiency. They are increasingly being adopted in environments where temperature stability is required, but the cost of water-jacketed models is prohibitive. Their compact design & lower operating costs contribute to their rapid growth, especially in emerging economies & academic research settings.

 

By Capacity:

Leading Segment: 100–200 Liters

The 100–200 liter capacity segment holds the largest market share, accounting for around 50% of the total CO2 incubator market. This capacity range is favored for its versatility, catering to both small & medium-scale laboratory environments, where the demand for cell culturing, microbiological & tissue culture applications is high. The widespread adoption of these incubators in research laboratories, clinical applications, and biotechnology firms drives their market dominance.

Fastest-Growing Segment: Above 200 Liters

The "Above 200 Liters" segment is the fastest-growing, with an expected CAGR of 7.1%. Larger incubators are increasingly required for high-volume research and industrial applications, especially in large-scale cell culture, biopharmaceutical production, and vaccine research. The growing emphasis on large-scale pharmaceutical production, along with the expansion of biotech companies, is driving the demand for larger capacity CO2 incubators.

 

By Application:

Leading Segment: Laboratory Research and Clinical Applications Laboratory research and clinical applications account for the largest share of the CO2 incubator market, with around 60% of the market share. The need for stable environments for cell culturing, microbiological studies, and in vitro studies in research labs is driving the demand for CO2 incubators. Clinical applications, particularly in hospitals and medical centers for diagnostic and therapeutic research, are further pushing the growth of this segment. The increasing focus on precision medicine, stem cell research, and personalized therapies also contributes to the growth of laboratory research and clinical applications.

Fastest-Growing Segment: In Vitro Fertilization

The in vitro fertilization (IVF) segment is the fastest-growing, projected to grow at a CAGR of 8% over the next few years. With the rise in fertility treatment demand & advancements in reproductive medicine, IVF procedures require highly controlled environments, making CO2 incubators essential. The increasing number of IVF treatments across the globe, particularly in developed countries & regions like Asia-Pacific, is a key factor in the rapid growth of this application.

 

By End User:

Leading Segment: Biotechnology and Pharmaceutical Companies Biotechnology and pharmaceutical companies are the leading end-users in the CO2 incubator market, accounting for around 40% of the market share. These companies use CO2 incubators for various applications, including drug development, cell-based research & biopharmaceutical production. The increasing demand for biologics, vaccines & other therapeutic products, along with growing investments in research and development, continues to propel the dominance of this segment.

Fastest-Growing Segment: Hospitals and Medical Centers

The fastest-growing end-user segment is hospitals and medical centers, with an expected CAGR of 7.4%. As hospitals expand their research capabilities and clinical applications in areas such as regenerative medicine, diagnostics, and personalized treatment, the demand for CO2 incubators is rising. Medical centers increasingly adopt these incubators for advanced cell culture applications, further accelerating their market growth.

 

By Region:

Leading Region: North America

North America holds the largest market share in the CO2 incubator market, accounting for approximately 40% of the total market share. The region’s leadership can be attributed to its robust healthcare infrastructure, a strong presence of leading biotechnology & pharmaceutical companies & advanced research facilities. The U.S., in particular, is a major contributor to this dominance, with substantial investments in medical research, clinical applications & IVF procedures.

Fastest-Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region for the CO2 incubator market, with a projected CAGR of 8.1%. The growing biotechnology industry, increasing investments in healthcare infrastructure & rising demand for IVF treatments are major contributors to the rapid growth in this region. Countries such as China, India & Japan are driving this expansion, as the need for advanced laboratory & medical research capabilities grows, alongside a burgeoning middle class & improved healthcare accessibility. The region's increasing focus on pharmaceutical research & clinical trials further contributes to the demand for CO2 incubators.

 

Key Players

• Thermo Fisher Scientific Inc.

• Eppendorf AG

• Memmert GmbH + Co. KG

• Sartorius AG

• PHC Holdings Corporation

• NuAire Inc.

• BINDER GmbH

• Sheldon Manufacturing Inc.

• Bellco Glass Inc.

• Benchmark Scientific Inc.

 

CO2 Incubator Market Report Coverage

Report Attribute	Details
Forecast Period	2023 – 2030
Market Size Value in 2023	USD 730 million
Revenue Forecast in 2030	USD 1,208.14 million
Overall Growth Rate	CAGR of 6.5%
Base Year for Estimation	2022
Historical Data	2017 – 2021
Unit	USD Million, CAGR (2023 - 2030)
Segmentation	By Product Type, By Capacity, By Application, By Region
By Product Type	Water-Jacketed CO2 Incubators, Air-Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Others
By Capacity	Below 100 Liters, 100–200 Liters, Above 200 Liters
By Application	Laboratory Research and Clinical Applications, In Vitro Fertilization, Others
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	US, Canada, Germany, UK, France, China, Japan, India, etc.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

 

Recent Development

• In June 2024, Thermo Fisher Scientific will present the Thermo ScientificTM HeracellTM VIOSTM 250i AxD CO2 Incubators to facilitate future workflow automation in cell therapy production. These unique CO2 incubators aim to be integrated into automated and modular labs. The VIOS range of incubators is renowned for its low risk of contamination and ideal conditions for cell growth. The Heracell VIOS AxD CO2 incubator with patent-pending automated door control now enhances continuous cell therapy production processes by enabling robotic loading and unloading of vessels, automatically opening when integrated into a centralized lab automation platform.

 

• In October 2023, Biosan introduced the CO2 Shaker CPS-20made, especially for use in CO2 incubators, and offered controlled orbital motion of the platform. CPS-20 yields repeatable results for cell culture development and is especially intended for usage in tough settings. In addition to protecting electronics from the CO2 incubator environment, the specially-made remote controller doesn't interfere with the experiment. The ability to undertake different operations and techniques in different cultivation containers is made possible by using five interchangeable platforms.